AKT1 and Alzheimer disease: The results of immunohistochemistry and RT-PCR showed that the QKR-treated AD mice showed higher levels of p-PI3K and p-Akt and lower levels of Aβ than the model group, indicating the role of QKR in increasing the activity of the PI3K/Akt pathway.